We provide you with 20 years of free, institutional-grade data for KRON stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of KRON. Explore the full financial landscape of KRON stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about KRON stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Kronos Bio Inc(NASDAQ:KRON) 
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery and development of new cancer therapies. The company is headquartered in San Mateo, California.
Website: https://www.kronosbio.com/
Founded: 2017
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Share this website to your friends